PROMETRIKA is proud to host a Live Webcast featuring Ken Getz, MBA, Executive Director of the Tufts Center for the Study of Drug Development, a leading authority on the empirical evaluation of clinical trials. Mr. Getz and Chelsey Ryan, PMP, Head of Clinical Operations and Pharmacovigilance at PROMETRIKA, will discuss decentralized clinical trials (DCTs).
- Learn what the evidence tells us about DCTs, including the pros and cons
- Understand the types of studies where DCT makes the most sense and how components of DCT can be implemented in more traditional study designs
- Participate in discussion with Ken and industry peers about how to advance DCTs for future research
Please REGISTER for the LIVE WEBCAST below.